Impact of 18F-FDG PET/CT as a valuable prognostic tool for the newly diagnosed multiple myeloma with extramedullary disease

Abstract

18F-FDG PET/CT (PET/CT) could be considered as a valuable tool to predict the long-term survivals in patients with newly diagnosed multiple myeloma (MM). It has the ability to distinguish metabolically active sites such as extramedullary disease (EMD) as well as bone damage with relatively high sensitivity and specificity. In this study, we attempted to evaluate the PET-CT as a prognostic tool for patients with newly diagnosed MM who have EMD.